TNXP
Tonix
--
--(--)
Market Open: --
--
--(--)
Post-Market: --
TNXP Profile
Tonix Pharmaceuticals Holding Corp.
A clinical-stage biopharmaceutical company focused on therapeutics to treat and prevent human disease and alleviate suffering
Pharmaceutical
11/16/2007
08/09/2013
NASDAQ Stock Exchange
81
12-31
Common stock
26 Main Street, Suite 101, Chatham, New Jersey 07928
--
Tonix Pharmaceuticals Holding Corp was founded in Nevada on November 16, 2007. The company is a clinical-stage biopharmaceutical company focused on the development of therapies and vaccines to treat and prevent human diseases and reduce suffering. The company has a large number of products under development, which are curated through in-house discovery, licensing, acquisitions, and collaborations with academic institutions and contract research organizations. The company continues to build capabilities in synthetic biology, precision medicine, protein engineering, medicinal chemistry, molecular biology, pharmacogenomics and clinical-scale manufacturing. The therapies the company is developing include small molecules and biological agents.